(1 - 25 from 46
)
Injecting a Dose of Energy Into a Vaccine Company - PharmaVoicewww.pharmavoice.com › news › injecting-a-dose-of-energy-into-...
www.pharmavoice.com
Vijay Samant runs on pure energy, and it's paying dividends. The dynamic president and CEO of Vical Inc. has made a habit of success, thanks in part to his ...
Vical abandons herpes vaccine after mid-stage miss - BioPharma Divewww.biopharmadive.com › news › vical-herpes-vaccine-failure-stock-down
www.biopharmadive.com
11 Jun — CEO Vijay Samant pointed out the study's placebo comparator arm hampered the treatment effect of Vical's vaccine. “We took careful measures ...
Vical shares tumble after Phase 2 trial of its genital herpes treatment ...www.proactiveinvestors.co.uk › companies › news
www.proactiveinvestors.co.uk
11 Jun — As a result, there was significantly less power to show a vaccine effect in this trial,” said Vical CEO Vijay Samant.
Vical's cancer immunotherapy fails in late-stage trial - PMLiVEwww.pmlive.com › pharma_news › vicals_cancer_immunotherapy_fails_i...
www.pmlive.com
13 Aug — ... efficacy endpoints, even though we believe it was well-designed and well-executed," said Vijay Samant, president and CEO of Vical.
sorted by relevance / date